C000024962 Holdings — Columbia Acorn USA
All 97 reported holdings of Columbia Acorn USA (C000024962) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Columbia Short Term Cash Fund | 3.32% | $10.66M |
| Exponent Inc. | 2.08% | $6.67M |
| Sprout Social Inc | 2.01% | $6.45M |
| Manhattan Assoc, Inc. | 1.94% | $6.21M |
| Fate Therapeutics, Inc. | 1.83% | $5.88M |
| Qualys Inc | 1.81% | $5.81M |
| Acceleron Pharma, Inc. | 1.65% | $5.30M |
| ITT Inc | 1.51% | $4.85M |
| Foresight Acquisition Corp | 1.50% | $4.81M |
| Saia Inc | 1.50% | $4.80M |
| Insmed Inc | 1.49% | $4.79M |
| J2 Global Inc | 1.48% | $4.75M |
| Churchill Downs, Inc. | 1.47% | $4.73M |
| Shoals Technologies Group Inc | 1.46% | $4.67M |
| Chemed Corp. | 1.43% | $4.57M |
| Eargo, Inc. | 1.42% | $4.56M |
| Lhc Group | 1.40% | $4.49M |
| Plug Power Inc | 1.40% | $4.49M |
| ImmunoGen Inc | 1.39% | $4.46M |
| Kura Oncology, Inc. | 1.39% | $4.45M |
| Five Below Inc | 1.38% | $4.44M |
| Globus Medical, Inc. | 1.37% | $4.38M |
| Pacific Biosciences of California Inc | 1.34% | $4.30M |
| Blackline, Inc. | 1.33% | $4.27M |
| National Research Corp | 1.31% | $4.21M |
| Avient Corp. | 1.27% | $4.07M |
| Boot Barn Holdings Inc | 1.27% | $4.06M |
| Amedisys Inc | 1.24% | $3.99M |
| CorVel Corp | 1.23% | $3.93M |
| Haemonetics Corp. | 1.23% | $3.93M |
| Houlihan Lokey Inc | 1.20% | $3.83M |
| Dorman Products Inc | 1.19% | $3.83M |
| SiteOne Landscape Supply Inc | 1.19% | $3.81M |
| Badger Meter Inc | 1.19% | $3.80M |
| Bwx Technologies, Inc. | 1.17% | $3.77M |
| Nanostring Technologies, Inc. | 1.12% | $3.58M |
| Upstart Holdings Inc | 1.11% | $3.56M |
| Wd-40 Co. | 1.10% | $3.53M |
| Bjs Wholesale Club, Inc. | 1.09% | $3.51M |
| Wingstop, Inc. | 1.08% | $3.46M |
| Anika Therapeutics, Inc. | 1.07% | $3.43M |
| Mirati Therapeutics, Inc. | 1.05% | $3.38M |
| Natera Inc | 1.05% | $3.37M |
| Si-Bone, Inc. | 1.04% | $3.32M |
| Colliers International Group Inc | 1.04% | $3.32M |
| Redfin Corp | 1.03% | $3.31M |
| ICF Intnl | 1.02% | $3.27M |
| Dreyfus Government Cash Manage | 1.02% | $3.26M |
| Q2 Holdings Inc | 1.02% | $3.26M |
| Reata Pharmaceuticals, Inc. | 1.01% | $3.25M |
| Atkore International Group Inc | 1.00% | $3.20M |
| Eplus, Inc. | 0.95% | $3.06M |
| LCI Industries | 0.95% | $3.06M |
| Skyline Champion Corp | 0.95% | $3.04M |
| Jfrog Ltd. | 0.94% | $3.03M |
| Curtiss-Wright Corporation | 0.94% | $3.03M |
| Inphi Corp. | 0.94% | $3.02M |
| Brunswick Corporation | 0.93% | $2.98M |
| Digitalocean Holdings, Inc. | 0.90% | $2.89M |
| Mimecast Ltd | 0.89% | $2.85M |
| Voyager Digital Ltd | 0.87% | $2.80M |
| Calix Inc | 0.87% | $2.79M |
| Endava PLC | 0.87% | $2.78M |
| Crispr Therapeutics AG | 0.86% | $2.75M |
| Advanced Energy Industries, Inc. | 0.85% | $2.74M |
| Olo, Inc. | 0.84% | $2.68M |
| Atrion Corp | 0.83% | $2.68M |
| Merchants Bancorp/IN | 0.83% | $2.65M |
| Cedar Fair LP | 0.82% | $2.63M |
| Planet Fitness Inc | 0.82% | $2.62M |
| Choice Hotels Intl, Inc. | 0.81% | $2.59M |
| Arcus Biosciences, Inc. | 0.79% | $2.53M |
| ON24 Inc | 0.78% | $2.50M |
| FirstCash Inc | 0.78% | $2.49M |
| Hamilton Lane Inc | 0.77% | $2.46M |
| Medallia Inc | 0.74% | $2.38M |
| Nuvation Bio, Inc. | 0.74% | $2.36M |
| Vroom Inc | 0.74% | $2.36M |
| Lakeland Finl Corp. | 0.74% | $2.36M |
| Nektar Therapeutics | 0.70% | $2.26M |
| Acadia Pharmaceuticals, Inc. | 0.69% | $2.23M |
| Kiniksa Pharmaceuticals Ltd. | 0.69% | $2.22M |
| Watts Water Technologies, Inc. | 0.68% | $2.18M |
| FirstService Corp | 0.62% | $2.00M |
| Elastic NV | 0.62% | $1.98M |
| Wendys Co. | 0.59% | $1.88M |
| UniFirst Corp/MA | 0.58% | $1.86M |
| American Well Corp | 0.56% | $1.81M |
| GCM Grosvenor Inc | 0.55% | $1.76M |
| Repligen Corp. | 0.52% | $1.68M |
| CyberArk Software Ltd | 0.51% | $1.64M |
| Inter Parfums Inc | 0.48% | $1.54M |
| Poshmark Inc | 0.43% | $1.38M |
| Comfort Syst USA, Inc. | 0.14% | $461.85K |
| Spx Corp. | 0.14% | $437.55K |
| LiveRamp Holdings Inc | 0.12% | $380.12K |
| JPMorgan | 0.03% | $109.74K |
C000024962 overview: performance, fees, allocation and SEC filings